Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,253
Total Claims
$1.3M
Drug Cost
1,159
Beneficiaries
$1,158
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
-59%
Opioid rate vs peers
1.6% vs 3.8% avg
-1%
Cost per patient vs peers
$1,158 vs $1,174 avg
+57%
Brand preference vs peers
13.9% vs 8.9% avg
Opioid Prescribing
1.6%
Opioid Rate
176
Opioid Claims
$1,702
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,536 claims · $1.2M
Generic: 9,532 claims · $161K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 147 | $191K |
| Apixaban | 143 | $132K |
| Dulaglutide | 67 | $111K |
| Sitagliptin Phosphate | 64 | $70K |
| Fluticasone/Umeclidin/Vilanter | 39 | $67K |
| Budesonide/Formoterol Fumarate | 77 | $63K |
| Semaglutide | 36 | $61K |
| Fluticasone Propion/Salmeterol | 49 | $40K |
| Fluticasone/Vilanterol | 56 | $40K |
| Sacubitril/Valsartan | 29 | $33K |
| Insulin Glargine,hum.Rec.Anlog | 42 | $27K |
| Tiotropium Bromide | 16 | $21K |
| Insulin Glargine/Lixisenatide | 15 | $20K |
| Albuterol Sulfate | 363 | $16K |
| Fluticasone Propion/Salmeterol | 26 | $16K |
Prescribing Profile
Patient Profile
70
Avg Age
60%
Female
2.15
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data